Specialist in | HCG Oncology

Introduction

Dr. Partha Sen is a highly accomplished Senior Consultant in Radiation Oncology with expertise in clinical oncology, advanced radiotherapy techniques, systemic oncology therapies, and oncology department development. He obtained his MBBS and MD (Radiotherapy) from the West Bengal University of Health Sciences. Later, he completed a two-year clinical fellowship at Tata Medical Center, Kolkata. He also holds the European Society for Medical Oncology (ESMO) Certificate in Medical Oncology.

Dr. Sen’s diverse professional background includes serving as an Assistant Professor at the Mahatma Gandhi Institute of Medical Sciences (Maharashtra) and as a Consultant Clinical Oncologist at Bhutan's apex referral center, the Jigme Dorji Wangchuk National Referral Hospital. In Bhutan, he played a key role in establishing a new Radiotherapy Department, overseeing machine installations, developing clinical standard operating procedures (SOPs), and supporting infrastructure development for the National Cancer Registry and cancer screening programs.

Before joining HCG, Dr. Sen was associated with Netaji Subhas Chandra Bose Cancer Hospital (Pancha Sayar, Kolkata) and Belle Vue Clinic (Kolkata). Dr. Sen combines advanced radiotherapy techniques with systemic management of solid tumors to deliver evidence-based and patient-centric cancer care.

Area of Expertise

●Dr. Partha Sen is a highly experienced Radiation Oncology Consultant at HCG Cancer Hospital, a leading comprehensive cancer hospital in Kolkata.

●With extensive experience in evidence-based clinical protocols, he specializes in the following areas:

⮚Advanced Radiation Modalities: 2D simulations, 3D Conformal Radiotherapy (3DCRT), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), and Tomotherapy planning, volumetric contouring, and rigorous plan reviews.

⮚Stereotactic Procedures: High-dose Stereotactic Radiotherapy (SRT) and Stereotactic Radiosurgery (SRS) workflows.

⮚Brachytherapy (Internal Radiation): High-Dose Rate (HDR), intravaginal, intrauterine, and intraluminal brachytherapy procedures (specifically targeting esophageal cancers).

⮚Systemic Therapies & Support: Chemotherapy regimens for solid tumors and safely managing multi-system chemotherapy complications.

⮚Acute Clinical Management: Complex oncology emergencies, stabilizing critical ward patients, and managing acute treatment toxicities.

●Dr. Sen is familiar with the following radiotherapy platforms and treatment planning systems:

⮚Linear Accelerators & Teletherapy: Novalis Tx (Varian), Varian Clinac iX, Elekta Compact, Tomotherapy systems, and conventional Cobalt-60 (Theratron 780 C).

⮚Treatment Planning Systems (TPS): Varian Eclipse and Elekta MONACO treatment planning software packages.

⮚Specialized Software Systems: BrainLab Stereotactic Radiosurgery system software and Nucletron Brachytherapy treatment platforms.

Research & Publications

Clinical Trials

●Clinical Trial Co-Investigator (Phase III Study): SB3-G31-BC Trial—A Phase III Randomized, Double-Blind, Parallel-Group, Multicenter Study comparing the Efficacy, Safety, Pharmacokinetics, and Immunogenicity between SB3 (proposed trastuzumab biosimilar) and Herceptin® in women with newly diagnosed HER2-positive early or locally advanced breast cancer in a neoadjuvant setting.

●Clinical Trial Co-Investigator (Phase IV Study): ML29282 Trial—A multicenter, open-label, single-arm study evaluating Pertuzumab (in combination with trastuzumab and docetaxel) as a first-line treatment pattern for Indian patients presenting with HER2-positive advanced (metastatic or locally recurrent) breast cancer.

Publications

●Primary Fallopian tube carcinoma with metastasis in the contralateral ovary: A Case report. Journal of Indian Medical Association (JIMA), 2012;110:494-5 & 498.

●Proptosis may be the only presenting feature of small cell lung cancer: A case report. Journal of Indian Medical Association (JIMA), 2013 March;111(3):198-199.

Awards & Accolades

Academic Contributions

●International Conference Faculty Guest: Appointed Guest Faculty Member at the 13th SAARC Federation of Oncologists (SFO) International Conference, 2018, held in Thimphu, Bhutan.

●National Conference Faculty Guest: Appointed Faculty Member at the 7th Young Radiation Oncologists Conference (YROC), 2019 in Siliguri, West Bengal, India.

● Postgraduate Teaching & Medical Mentorship: Actively engaged in lecturing postgraduate radiotherapy trainees at MGIMS, Wardha (Maharashtra), and directed primary orientation courses on oncology emergencies for Emergency Residents and rotating Interns at JDWNRH, Bhutan.

Presentations

●Peer-Reviewed Scientific Presentations: Presented 'Neoadjuvant Chemoradiation for Rectal Cancer: An audit of acute toxicity, response, and local control' at the Annual State Conference of the Association of Radiation Oncologists of India (AROI) West Bengal Chapter, 2016.

Administrative Contributions

● Conference Organization & Institutional Liaison: Served as core organizer for the Annual Controversies in Clinical Oncology Conference, coordinating conference operations and securing formal Continuing Medical Education (CME) credit hour accreditations from the West Bengal Medical Council (WBMC).

●Acted as key venue coordinator for the Varian IGRT teaching course and ICRO lung cancer teaching symposiums.

Other Doctors